ID   D5EY68_XYLR2            Unreviewed;       875 AA.
AC   D5EY68;
DT   15-JUN-2010, integrated into UniProtKB/TrEMBL.
DT   15-JUN-2010, sequence version 1.
DT   05-FEB-2025, entry version 72.
DE   SubName: Full=Glycosyl hydrolase, family 3 {ECO:0000313|EMBL:ADE81565.1};
GN   OrderedLocusNames=PRU_2786 {ECO:0000313|EMBL:ADE81565.1};
OS   Xylanibacter ruminicola (strain ATCC 19189 / DSM 19721 / CIP 105475 / JCM
OS   8958 / 23) (Prevotella ruminicola).
OC   Bacteria; Bacteroidota; Bacteroidia; Bacteroidales; Prevotellaceae;
OC   Xylanibacter.
OX   NCBI_TaxID=264731 {ECO:0000313|EMBL:ADE81565.1, ECO:0000313|Proteomes:UP000000927};
RN   [1] {ECO:0000313|EMBL:ADE81565.1, ECO:0000313|Proteomes:UP000000927}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 19189 / JCM 8958 / 23 {ECO:0000313|Proteomes:UP000000927};
RX   PubMed=20585943; DOI=10.1007/s00248-010-9692-8;
RG   North American Consortium for Rumen Bacteria;
RA   Purushe J., Fouts D.E., Morrison M., White B.A., Mackie R.I.,
RA   Coutinho P.M., Henrissat B., Nelson K.E.;
RT   "Comparative genome analysis of Prevotella ruminicola and Prevotella
RT   bryantii: insights into their environmental niche.";
RL   Microb. Ecol. 60:721-729(2010).
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 3 family.
CC       {ECO:0000256|ARBA:ARBA00005336}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP002006; ADE81565.1; -; Genomic_DNA.
DR   RefSeq; WP_013063552.1; NC_014033.1.
DR   AlphaFoldDB; D5EY68; -.
DR   STRING; 264731.PRU_2786; -.
DR   CAZy; GH3; Glycoside Hydrolase Family 3.
DR   KEGG; pru:PRU_2786; -.
DR   eggNOG; COG1472; Bacteria.
DR   HOGENOM; CLU_004542_5_3_10; -.
DR   Proteomes; UP000000927; Chromosome.
DR   GO; GO:0046556; F:alpha-L-arabinofuranosidase activity; IEA:TreeGrafter.
DR   GO; GO:0009044; F:xylan 1,4-beta-xylosidase activity; IEA:InterPro.
DR   GO; GO:0031222; P:arabinan catabolic process; IEA:TreeGrafter.
DR   GO; GO:0045493; P:xylan catabolic process; IEA:InterPro.
DR   Gene3D; 3.40.50.1700; Glycoside hydrolase family 3 C-terminal domain; 2.
DR   Gene3D; 3.20.20.300; Glycoside hydrolase, family 3, N-terminal domain; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR044993; BXL.
DR   InterPro; IPR026891; Fn3-like.
DR   InterPro; IPR002772; Glyco_hydro_3_C.
DR   InterPro; IPR036881; Glyco_hydro_3_C_sf.
DR   InterPro; IPR001764; Glyco_hydro_3_N.
DR   InterPro; IPR036962; Glyco_hydro_3_N_sf.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR037524; PA14/GLEYA.
DR   InterPro; IPR011658; PA14_dom.
DR   PANTHER; PTHR42721:SF3; BETA-D-XYLOSIDASE 5-RELATED; 1.
DR   PANTHER; PTHR42721; SUGAR HYDROLASE-RELATED; 1.
DR   Pfam; PF14310; Fn3-like; 1.
DR   Pfam; PF00933; Glyco_hydro_3; 1.
DR   Pfam; PF01915; Glyco_hydro_3_C; 1.
DR   Pfam; PF07691; PA14; 1.
DR   PRINTS; PR00133; GLHYDRLASE3.
DR   SMART; SM01217; Fn3_like; 1.
DR   SMART; SM00758; PA14; 1.
DR   SUPFAM; SSF51445; (Trans)glycosidases; 1.
DR   SUPFAM; SSF56988; Anthrax protective antigen; 1.
DR   SUPFAM; SSF52279; Beta-D-glucan exohydrolase, C-terminal domain; 1.
DR   PROSITE; PS51820; PA14; 1.
PE   3: Inferred from homology;
KW   Hydrolase {ECO:0000256|ARBA:ARBA00022801, ECO:0000313|EMBL:ADE81565.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000000927};
KW   Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           18..875
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5003071181"
FT   DOMAIN          475..618
FT                   /note="PA14"
FT                   /evidence="ECO:0000259|PROSITE:PS51820"
SQ   SEQUENCE   875 AA;  96945 MW;  CD6181556CC94CC0 CRC64;
     MKRLLMMSLF VGFCATAMDA QGLPYQNANL SAAQRADDLL SRLTLDEKVS LMMDTSPAIP
     RLGIPQFQWW NEALHGIGRN GFATVFPITM AMAASWDDAL LHQVFTAVSD EARVKAQQAK
     CTGDIKRYQS LSFWTPNINI FRDPRWGRGQ ETYGEDPYLT AKMGLAVVRG LQGVGYNGED
     LGVSKYRKLL ACAKHFAVHS GPEWNRHEFN IENLPERDLW ETYLPAFKAL VQEGKVAEVM
     CAYQRIDGQA CCAQTRYEQQ ILRDEWGFDG LITSDCGAIR DFLPRWHNVS KDGAEASAKA
     VLAGTDVECG SEYKHLPEAV RRGDVKEADI DRSLRRLLIA RFELGDMDSD DLNAWTKIPE
     TVVASQAHKD LALKMALKSI VLLQNKIKVL PLGNPLNAGA GSDKDIVVMG PNANDSVMMW
     GNYAGYPTHT VTALDGITRM AKTLSPDATV RFIQGCGLTR NEVFESRFNQ IKDPLGNSGI
     QIAYWNNTEM QGAPVTVVNR KQPVQLSNGG NTVFAPGVNL ENCSARLDGT LVPTADETLS
     FEISGDDRLR LIVNGDTLVN IWNPRQRIQS GKKEIAVKAG QHYRIQIDYV QETGYGALNF
     DIKKRVNPTA EELLAQIGNT QTIIFVGGIS PNLEGEEMRV NEPGFKGGDR TSIELPQAQR
     DLLAVLHKAG KKVIFVNCSG SAMALAPELE TCDAILQWWY GGEQGGAALA TTLFGMVAPS
     GKLPVTFYKS TDELPDFLDY TMKNRTYRYY EGEPLFPFGF GLGYTTFNID KPIYKNNKVQ
     VRVKNLGTTA GTETVQVYIR HLADKEGPKK SLRAYQQVTL NAAEAKTISI ELPRKSFEGW
     DVKTNTMRVV PGKYEVMVGN SSADKDLKKI IVNIK
//
